Global Human Fibrinogen Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030

Global Human Fibrinogen Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030


Summary

Fibrinogen (factor I) is a glycoprotein in vertebrates that helps in the formation of blood clots. Human Fibrinogen is used as a medicine for blood disease. Human Fibrinogen is a preparation of coagulation factors prepared from pooled plasma. Currently, only RiaSTAP (CSL Behring) is licensed in a number of countries for multiple indications including treating acute bleeding episodes with Hypofibrinogenemia. Other manufacturer’s products are justly used in local region or countries.

According to APO Research, The global Human Fibrinogen market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Human Fibrinogen is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Human Fibrinogen is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Human Fibrinogen is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Human Fibrinogen is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Human Fibrinogen include CSL Behring, LFB Group, Shanghai RAAS Blood Products, Jiangxi Boya Bio-Pharmaceutical, Hualan Biological Engineering, Harbin Pacific Biopharmaceutical, GREEN CROSS, Shanghai XinXing Medical and Octapharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Human Fibrinogen, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Human Fibrinogen, also provides the sales of main regions and countries. Of the upcoming market potential for Human Fibrinogen, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Human Fibrinogen sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Human Fibrinogen market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Human Fibrinogen sales, projected growth trends, production technology, application and end-user industry.

Human Fibrinogen segment by Company

CSL Behring
LFB Group
Shanghai RAAS Blood Products
Jiangxi Boya Bio-Pharmaceutical
Hualan Biological Engineering
Harbin Pacific Biopharmaceutical
GREEN CROSS
Shanghai XinXing Medical
Octapharma
Human Fibrinogen segment by Type

Human Fibrinogen Concentrate
Animal Fibrinogen Concentrate
Human Fibrinogen segment by Application

Congenital Fibrinogen Deficiency
Surgical Procedures
Human Fibrinogen segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Fibrinogen market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Human Fibrinogen and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Fibrinogen.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Human Fibrinogen market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2019-2030).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Fibrinogen manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Human Fibrinogen in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Human Fibrinogen in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report


1 Market Overview
1.1 Product Definition
1.2 Global Human Fibrinogen Market Size, 2019 VS 2023 VS 2030
1.3 Global Human Fibrinogen Market Size Estimates and Forecasts (2019-2030)
1.4 Global Human Fibrinogen Sales Estimates and Forecasts (2019-2030)
1.5 Global Human Fibrinogen Market Average Price (2019-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Human Fibrinogen Market Dynamics
2.1 Human Fibrinogen Industry Trends
2.2 Human Fibrinogen Industry Drivers
2.3 Human Fibrinogen Industry Opportunities and Challenges
2.4 Human Fibrinogen Industry Restraints
3 Human Fibrinogen Market by Manufacturers
3.1 Global Human Fibrinogen Revenue by Manufacturers (2019-2024)
3.2 Global Human Fibrinogen Sales by Manufacturers (2019-2024)
3.3 Global Human Fibrinogen Average Sales Price by Manufacturers (2019-2024)
3.4 Global Human Fibrinogen Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Human Fibrinogen Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Human Fibrinogen Manufacturers, Product Type & Application
3.7 Global Human Fibrinogen Manufacturers Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Human Fibrinogen Market CR5 and HHI
3.8.2 Global Top 5 and 10 Human Fibrinogen Players Market Share by Revenue in 2023
3.8.3 2023 Human Fibrinogen Tier 1, Tier 2, and Tier 3
4 Human Fibrinogen Market by Type
4.1 Human Fibrinogen Type Introduction
4.1.1 Human Fibrinogen Concentrate
4.1.2 Animal Fibrinogen Concentrate
4.2 Global Human Fibrinogen Sales by Type
4.2.1 Global Human Fibrinogen Sales by Type (2019 VS 2023 VS 2030)
4.2.2 Global Human Fibrinogen Sales by Type (2019-2030)
4.2.3 Global Human Fibrinogen Sales Market Share by Type (2019-2030)
4.3 Global Human Fibrinogen Revenue by Type
4.3.1 Global Human Fibrinogen Revenue by Type (2019 VS 2023 VS 2030)
4.3.2 Global Human Fibrinogen Revenue by Type (2019-2030)
4.3.3 Global Human Fibrinogen Revenue Market Share by Type (2019-2030)
5 Human Fibrinogen Market by Application
5.1 Human Fibrinogen Application Introduction
5.1.1 Congenital Fibrinogen Deficiency
5.1.2 Surgical Procedures
5.2 Global Human Fibrinogen Sales by Application
5.2.1 Global Human Fibrinogen Sales by Application (2019 VS 2023 VS 2030)
5.2.2 Global Human Fibrinogen Sales by Application (2019-2030)
5.2.3 Global Human Fibrinogen Sales Market Share by Application (2019-2030)
5.3 Global Human Fibrinogen Revenue by Application
5.3.1 Global Human Fibrinogen Revenue by Application (2019 VS 2023 VS 2030)
5.3.2 Global Human Fibrinogen Revenue by Application (2019-2030)
5.3.3 Global Human Fibrinogen Revenue Market Share by Application (2019-2030)
6 Global Human Fibrinogen Sales by Region
6.1 Global Human Fibrinogen Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Human Fibrinogen Sales by Region (2019-2030)
6.2.1 Global Human Fibrinogen Sales by Region (2019-2024)
6.2.2 Global Human Fibrinogen Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Human Fibrinogen Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.3.2 North America Human Fibrinogen Sales by Country (2019-2030)
6.3.3 U.S.
6.3.4 Canada
6.4 Europe
6.4.1 Europe Human Fibrinogen Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.4.2 Europe Human Fibrinogen Sales by Country (2019-2030)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Human Fibrinogen Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.5.2 Asia Pacific Human Fibrinogen Sales by Country (2019-2030)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 LAMEA
6.6.1 LAMEA Human Fibrinogen Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.6.2 LAMEA Human Fibrinogen Sales by Country (2019-2030)
6.6.3 Mexico
6.6.4 Brazil
6.6.5 Turkey
6.6.6 GCC Countries
7 Global Human Fibrinogen Revenue by Region
7.1 Global Human Fibrinogen Revenue by Region
7.1.1 Global Human Fibrinogen Revenue by Region: 2019 VS 2023 VS 2030
7.1.2 Global Human Fibrinogen Revenue by Region (2019-2024)
7.1.3 Global Human Fibrinogen Revenue by Region (2025-2030)
7.1.4 Global Human Fibrinogen Revenue Market Share by Region (2019-2030)
7.2 North America
7.2.1 North America Human Fibrinogen Revenue (2019-2030)
7.2.2 North America Human Fibrinogen Revenue Share by Country: 2019 VS 2023 VS 2030
7.3 Europe
7.3.1 Europe Human Fibrinogen Revenue (2019-2030)
7.3.2 Europe Human Fibrinogen Revenue Share by Country: 2019 VS 2023 VS 2030
7.4 Asia-Pacific
7.4.1 Asia-Pacific Human Fibrinogen Revenue (2019-2030)
7.4.2 Asia-Pacific Human Fibrinogen Revenue Share by Country: 2019 VS 2023 VS 2030
7.5 LAMEA
7.5.1 LAMEA Human Fibrinogen Revenue (2019-2030)
7.5.2 LAMEA Human Fibrinogen Revenue Share by Country: 2019 VS 2023 VS 2030
8 Company Profiles
8.1 CSL Behring
8.1.1 CSL Behring Comapny Information
8.1.2 CSL Behring Business Overview
8.1.3 CSL Behring Human Fibrinogen Sales, Price, Revenue and Gross Margin (2019-2024)
8.1.4 CSL Behring Human Fibrinogen Product Portfolio
8.1.5 CSL Behring Recent Developments
8.2 LFB Group
8.2.1 LFB Group Comapny Information
8.2.2 LFB Group Business Overview
8.2.3 LFB Group Human Fibrinogen Sales, Price, Revenue and Gross Margin (2019-2024)
8.2.4 LFB Group Human Fibrinogen Product Portfolio
8.2.5 LFB Group Recent Developments
8.3 Shanghai RAAS Blood Products
8.3.1 Shanghai RAAS Blood Products Comapny Information
8.3.2 Shanghai RAAS Blood Products Business Overview
8.3.3 Shanghai RAAS Blood Products Human Fibrinogen Sales, Price, Revenue and Gross Margin (2019-2024)
8.3.4 Shanghai RAAS Blood Products Human Fibrinogen Product Portfolio
8.3.5 Shanghai RAAS Blood Products Recent Developments
8.4 Jiangxi Boya Bio-Pharmaceutical
8.4.1 Jiangxi Boya Bio-Pharmaceutical Comapny Information
8.4.2 Jiangxi Boya Bio-Pharmaceutical Business Overview
8.4.3 Jiangxi Boya Bio-Pharmaceutical Human Fibrinogen Sales, Price, Revenue and Gross Margin (2019-2024)
8.4.4 Jiangxi Boya Bio-Pharmaceutical Human Fibrinogen Product Portfolio
8.4.5 Jiangxi Boya Bio-Pharmaceutical Recent Developments
8.5 Hualan Biological Engineering
8.5.1 Hualan Biological Engineering Comapny Information
8.5.2 Hualan Biological Engineering Business Overview
8.5.3 Hualan Biological Engineering Human Fibrinogen Sales, Price, Revenue and Gross Margin (2019-2024)
8.5.4 Hualan Biological Engineering Human Fibrinogen Product Portfolio
8.5.5 Hualan Biological Engineering Recent Developments
8.6 Harbin Pacific Biopharmaceutical
8.6.1 Harbin Pacific Biopharmaceutical Comapny Information
8.6.2 Harbin Pacific Biopharmaceutical Business Overview
8.6.3 Harbin Pacific Biopharmaceutical Human Fibrinogen Sales, Price, Revenue and Gross Margin (2019-2024)
8.6.4 Harbin Pacific Biopharmaceutical Human Fibrinogen Product Portfolio
8.6.5 Harbin Pacific Biopharmaceutical Recent Developments
8.7 GREEN CROSS
8.7.1 GREEN CROSS Comapny Information
8.7.2 GREEN CROSS Business Overview
8.7.3 GREEN CROSS Human Fibrinogen Sales, Price, Revenue and Gross Margin (2019-2024)
8.7.4 GREEN CROSS Human Fibrinogen Product Portfolio
8.7.5 GREEN CROSS Recent Developments
8.8 Shanghai XinXing Medical
8.8.1 Shanghai XinXing Medical Comapny Information
8.8.2 Shanghai XinXing Medical Business Overview
8.8.3 Shanghai XinXing Medical Human Fibrinogen Sales, Price, Revenue and Gross Margin (2019-2024)
8.8.4 Shanghai XinXing Medical Human Fibrinogen Product Portfolio
8.8.5 Shanghai XinXing Medical Recent Developments
8.9 Octapharma
8.9.1 Octapharma Comapny Information
8.9.2 Octapharma Business Overview
8.9.3 Octapharma Human Fibrinogen Sales, Price, Revenue and Gross Margin (2019-2024)
8.9.4 Octapharma Human Fibrinogen Product Portfolio
8.9.5 Octapharma Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Human Fibrinogen Value Chain Analysis
9.1.1 Human Fibrinogen Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Human Fibrinogen Production Mode & Process
9.2 Human Fibrinogen Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Human Fibrinogen Distributors
9.2.3 Human Fibrinogen Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings